Intravenous Infusions Plc (GHSE:IIL)
Ghana
· Delayed Price · Currency is GHS 0.0500
0.00 (0.00%)
At close: Feb 16, 2026
Intravenous Infusions Balance Sheet
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.19 | 1.49 | 0.29 | 0.95 | 0.81 | Upgrade
|
| Cash & Short-Term Investments | 0.19 | 1.49 | 0.29 | 0.95 | 0.81 | Upgrade
|
| Cash Growth | -87.34% | 405.98% | -69.17% | 18.07% | -16.05% | Upgrade
|
| Accounts Receivable | 7.27 | 10.23 | 15.07 | 15.13 | 15.74 | Upgrade
|
| Other Receivables | - | 2.41 | 1.44 | 1.77 | 1.79 | Upgrade
|
| Receivables | 7.27 | 12.63 | 16.51 | 16.9 | 17.53 | Upgrade
|
| Inventory | 5.16 | 6.09 | 6.26 | 6.63 | 7.65 | Upgrade
|
| Prepaid Expenses | - | 0.06 | 0.09 | 0.07 | 0.09 | Upgrade
|
| Total Current Assets | 12.62 | 20.26 | 23.15 | 24.55 | 26.08 | Upgrade
|
| Property, Plant & Equipment | 23.8 | 24.5 | 23.26 | 22.21 | 20.41 | Upgrade
|
| Long-Term Investments | - | 0.01 | 0.01 | - | - | Upgrade
|
| Other Intangible Assets | - | 0.07 | 0.07 | 0.06 | 0.06 | Upgrade
|
| Total Assets | 36.41 | 44.84 | 46.49 | 46.82 | 46.55 | Upgrade
|
| Accounts Payable | 14.47 | 12.21 | 9.33 | 8.52 | 7.1 | Upgrade
|
| Accrued Expenses | - | 0.05 | 0.18 | 0.18 | 0.2 | Upgrade
|
| Short-Term Debt | - | 0.87 | 1.23 | 1.64 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.68 | 3.94 | 3.94 | 4.09 | 2.54 | Upgrade
|
| Current Portion of Leases | - | 0.01 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Current Income Taxes Payable | - | - | 0 | - | - | Upgrade
|
| Other Current Liabilities | - | 7.31 | 6.15 | 6.96 | 4.15 | Upgrade
|
| Total Current Liabilities | 15.15 | 24.4 | 20.86 | 21.4 | 14 | Upgrade
|
| Long-Term Debt | 9.62 | 3.94 | 7.88 | 10.36 | 13.81 | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.59 | 0.55 | 0.39 | 0.25 | 0.41 | Upgrade
|
| Other Long-Term Liabilities | -0.35 | - | - | - | - | Upgrade
|
| Total Liabilities | 25 | 28.93 | 29.17 | 32.04 | 28.26 | Upgrade
|
| Common Stock | 11.63 | 11.63 | 11.63 | 11.63 | 11.63 | Upgrade
|
| Additional Paid-In Capital | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | Upgrade
|
| Retained Earnings | -2.31 | 2.18 | 3.59 | 1.05 | 4.56 | Upgrade
|
| Shareholders' Equity | 11.42 | 15.91 | 17.32 | 14.78 | 18.29 | Upgrade
|
| Total Liabilities & Equity | 36.41 | 44.84 | 46.49 | 46.82 | 46.55 | Upgrade
|
| Total Debt | 10.3 | 8.81 | 13.12 | 16.13 | 16.39 | Upgrade
|
| Net Cash (Debt) | -10.11 | -7.32 | -12.83 | -15.18 | -15.58 | Upgrade
|
| Net Cash Per Share | -0.04 | -0.03 | -0.05 | -0.06 | -0.06 | Upgrade
|
| Filing Date Shares Outstanding | 283.84 | 274.41 | 274.41 | 274.41 | 274.41 | Upgrade
|
| Total Common Shares Outstanding | 283.84 | 274.41 | 274.41 | 274.41 | 274.41 | Upgrade
|
| Working Capital | -2.53 | -4.14 | 2.29 | 3.15 | 12.08 | Upgrade
|
| Book Value Per Share | 0.04 | 0.06 | 0.06 | 0.05 | 0.07 | Upgrade
|
| Tangible Book Value | 11.42 | 15.84 | 17.25 | 14.72 | 18.23 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.06 | 0.06 | 0.05 | 0.07 | Upgrade
|
| Land | - | 3.74 | 3.74 | 3.74 | 2.66 | Upgrade
|
| Machinery | - | 8.79 | 8.74 | 5.59 | 5.48 | Upgrade
|
| Construction In Progress | - | 18.12 | 16.31 | 17.63 | 16.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.